Home » Topics » BioWorld Science

BioWorld Science
RSS

Sarepta partners with Myonexus to advance gene therapies for limb-girdle muscular dystrophy

May 4, 2018

EMA validates type II variation application for Opdivo plus Yervoy in first-line NSCLC

May 4, 2018

OTL-200 receives rare pediatric disease designation from the FDA

May 4, 2018

Casma Therapeutics launched to develop breakthrough therapies by boosting autophagy

May 4, 2018

DLK inhibitor shows promising data in vivo

May 4, 2018

First patient dosed in phase II study of AG-10 in ATTR cardiomyopathy

May 4, 2018

Altum Pharmaceuticals acquires Lexi Pharma

May 4, 2018

FDA approves AndexXa to reverse factor Xa inhibitors

May 4, 2018

New albumin-binding compounds from CytRx show antitumor activity in xenograft models

May 4, 2018

Moderna Therapeutics and Merck & Co. expand cancer collaboration

May 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...